202213 Jun

Onkos Surgical Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis

Summary

PARSIPPANY, N.J., June 13, 2022 /PRNewswire/ -- Onkos Surgical, Inc., a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic conditions, announced today that it has entered into a definitive agreement with Stryker to acquire the Juvenile Tumour System (JTS). Onkos is a specialty MedTech company that is focused on developing solutions for surgeons who specialize in musculoskeletal oncology and other complex orthopaedic conditions. We are proud to collaborate with this dedicated surgeon community and excited to create a bright future for the technology as we continue this meaningful work for pediatric musculoskeletal cancer patients." Our personalized approach supports improved patient outcomes and experiences using the latest innovations in virtual surgical planning, 3D anatomic modeling and printing, implant design, and workflow optimization. Forward-looking statements are based upon managements beliefs, assumptions and current expectations but are subject to known and unknown risks and uncertainties including, without limitation, market trends and demand, supply chain interruptions and other potential effects of the continuing COVID-19 pandemic.

Source: Biospace

Classifications

Companies